Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience

Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience

Background and Objectives: Relapsed/refractory extramedullary myeloma (RREMM) is an uncommon and aggressive subtype of multiple myeloma defined by plasma cell proliferation outside the bone marrow. Therapeutic options for RREMM are limited, and the prognosis is generally unfavorable. This research a...

Full description

Bibliographic Details
Main Authors: İbrahim Halil Açar, Birol Güvenç
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Hematology Reports
Subjects:
relapsed/refractory extramedullary myeloma
bendamustine
pomalidomide
dexamethasone
treatment outcomes
multiple myeloma
Online Access:https://www.mdpi.com/2038-8330/15/3/48

Internet

https://www.mdpi.com/2038-8330/15/3/48

Similar Items